Urinary tract infections in adults : a guideline-based management
Abstract
Urinary tract infections (UTIs) are frequent, especially in women. The increase in antibiotic resistance and changing epidemiological profiles require the recommendations to be regularly updated. This article reviews current guidelines for the management of uncomplicated and recurrent UTIs, taking into account recommendations from the European Association of Urology (EAU), the Association Française d'Urologie (AFU) and the American Association of Urology (AUA). While uncomplicated UTIs are generally treated with fosfomycin, nitrofurantoin or Cotrimoxazole, complicated UTIs require urine culture and often imaging, depending on their clinical presentation. The importance of precise targeting of treatments and preventive measures to limit bacterial resistance is underligned.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.